首页> 外文期刊>Hospital pharmacy. >State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions
【24h】

State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions

机译:药房的特权状况:幻想附属机构的调查

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The process of privileging pharmacists is an important step in developing optimal pharmacy practice models. Currently, little published literature exists detailing the status of pharmacist privileging efforts. The objective of this study is to assess and characterize a snapshot of the current and future state of privileging practices in pharmacy at Vizient academic medical centers (AMCs) and their affiliate institutions. Methods: An electronic survey questionnaire was sent to Vizient pharmacy directors and their affiliates to assess institutional privileging practices and identify perceived or actual barriers. The survey was divided into 2 pathways based on the current status of privileging at the institution. Results: In total, 46 directors of pharmacy completed the survey. Only 33% (15/46) of pharmacy directors indicated they had a current privileging process in place. About 70% (21/30) of institutions without an established privileging process indicated they were considering establishing a process. For institutions without an established privileging process, most pharmacy directors identified a lack of organizational support and resources as barriers to implementation. Conclusion: Although credentialing and privileging is considered a national priority to aid in expanding and enhancing pharmacists’ scope of practice, our survey demonstrated that few respondents currently have a privileging process in place. The results from this study may highlight important barriers and keys to success to be considered when implementing a privileging process.
机译:目的:特权药剂师的过程是开发最佳药学实践模型的重要一步。目前,少出版的文学存在细节药剂师特权努力的地位。本研究的目的是评估和描述幻想学术医疗中心(AMCS)及其联盟机构药房的当前和未来缔约国的快照。方法:电子调查问卷被送往Vizient Pharmacy董事及其关联公司,以评估机构特权实践并确定感知或实际障碍。该调查基于机构特权的现状分为2个途径。结果:共有46名药房董事完成调查。只有33%(15/46)的药房董事表明他们有一个目前的特权进程。大约70%(21/30)的机构没有建立的特权进程表明他们正在考虑建立一个过程。对于没有既定特权进程的机构,大多数药房董事将缺乏组织支持和资源作为实施的障碍。结论:虽然凭证和特权被认为是援助扩大和提高药剂师的实践范围的国家优先事项,但我们的调查显示,目前有很少的受访者目前有一个特权进程。本研究的结果可能会在实施特权进程时突出重要的障碍和钥匙,以便在实施特权进程时被视为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号